4Fletcher GF, Flipse TR, Kligfield P, et al. Current status of ECG stress testing. Curt Probl Cardiol, 1998,23 : 353-423.
5West NE,Ruygrok PN,Disco CM,et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation ,2004,109 : 867-873.
6Lakkireddy DR, Bhakkad J, Korlakunta HL, et al. Prognostic value of the Duke Treadmill Score in diabetic patients. Am Heart J, 2005,150:516-521.
7Doi A,Tsuchihashi K, Kyuma M, et al. Diagnostic implications of modified treadmill and head-up tilt tests in exercise-related syncope: comparative studies with situational and/or vasovagal syncope. Can J Cardiol,2002,18:960-966.
8黄海云.运动高血压对高血压的预测价值[J].中国循环杂志,2000,15:230-230.
二级参考文献6
1Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med, 2007, 356 : 998-1008.
2Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation,2007, 115 : 813-818.
3Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med ,2008, 359 : 1330-1342.
4Seung KB, Park DW, Kim YH, et al. Stents versus coronaryartery bypass grafting for left main coronary artery disease. N Engl J Med,2008, 358 : 1781-1792.
5Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med, 2007, 356: 1020-1029.
6Mauri L, Silbaugh TS, Wolf RE, et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in massachusetts. Circulation,2008, 118: 1817-1827.
